Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Risk Management Could Bolster FDA Behind-The-Counter Switches – Gottlieb

Executive Summary

FDA's authority to require behind-the-counter sale and other restrictions for some nonprescription switches is strengthened by risk management provisions of "FDA Revitalization" bills pending in Congress, according to former FDA Deputy Commissioner Scott Gottlieb

You may also be interested in...



BTC Class Might Not Happen Soon But FDA Working On Specific Proposal

Stakeholders in the concept of creating a behind-the-counter status for some drugs are at loggerheads on the need for a BTC class but agree on one point - FDA will need a long time to reach a decision on the issue

BTC Class Might Not Happen Soon But FDA Working On Specific Proposal

Stakeholders in the concept of creating a behind-the-counter status for some drugs are at loggerheads on the need for a BTC class but agree on one point - FDA will need a long time to reach a decision on the issue

Risk Management Only Part Of Behind-The-Counter Orders – Von Eschenbach

Enactment of legislation to strengthen FDA's post-marketing authority is not the only hurdle to clear before the agency could begin requiring "behind-the-counter" sales of certain nonprescription drugs, Commissioner Andrew von Eschenbach says

Related Content

UsernamePublicRestriction

Register

PS048549

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel